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Deoxyribonucleate (DNA) preparations were extracted from Neisseria men-
ingitidis (four isolates from spinal fluid and blood) and N. gonorrhoeae strains, all
of which were resistant to sulfadiazine upon primary isolation. These DNA prepara-
tions, together with others from in vitro mutants of N. meningitidis and N. perflava,
were examined in transformation tests by using as recipient a drug-susceptible
strain of N. meningitidis (Ne 15 Sul-s Met+) which was able to grow in a methionine-
free defined medium. The sulfadiazine resistance typical of each donor was intro-
duced into the uniform constitution of this recipient. Production of p-aminobenzoic
acid was not significantly altered thereby. Transformants elicited by DNA from the
N. meningitidis clinical isolates were resistant to at least 200 ,ug of sulfadiazine/ml,
and did not show a requirement for methionine (Sul-r Met+). DNA from six strains
of N. gonorrhoeae, which were isolated during the period of therapeutic use of sul-
fonamides, conveyed lower degrees of resistance and, invariably, a concurrent
methionine requirement (Sul-r/Met-). The requirement of these transformants, and
that of in vitro mutants selected on sulfadiazine-agar, was satisfied by methionine,
but not by vitamin B12, homocysteine, cystathionine, homoserine, or cysteine. Sul-r
Met+ and Sul-r/Met- loci could coexist in the same genome, but were segregated
during transformation. On the other hand, the dual Sul-r/Met- properties were not
separated by recombination, but were eliminated together. DNA from various
Sul-r/Met- clones tested against recipients having nonidentical Sul-r/Met- mutant
sites yielded Sul-s Met+ transformants. The met locus involved is genetically com-
plex, and will be a valuable tool for studies of genetic fine structure of members of
Neisseria, and of genetic homology between species.
Sulfonamides became available for clinical use
in 1936-37. At that time, they were highly effec-
tive both in vivo and in vitro against most strains
of Neisseria gonorrhoeae and N. meningitidis.
Subsequently, they became decreasingly effective
for treatment of gonorrhea, and 75 to 85% of
N. gonorrhoeae strains isolated from 1944 to 1948
were sulfonamide-resistant (31, 37). However,
N. meningitidis remained susceptible, and sulfon-
amides continued to be the drugs of choice for
meningococcal meningitis until recently. In 1963,
sulfonamide-resistant meningococcal strains were
implicated in outbreaks of meningitis among
military recruits (28), and subsequently have been
isolated from civilian cases (12, 26).
As a basis for understanding the natural evolu-
tion of bacterial resistance to an antimicrobial
agent, it is necessary to examine and compare
strains isolated from clinical material. Yet sulfon-
amide resistance which arises by mutation in
different strains is difficult to equate, inasmuch as
the same mutation may not have the same pheno-
typic effect when it occurs in cells of different
genetic constitution (29). The dilemma is resolved
by introducing the mutant information from
various clinical isolates into a selected recipient
strain which has a uniform genetic and physio-
logical constitution. The availability of a method
to accomplish this genetic transfer between vari-
ous species of Neisseria (2, 3), and of a completely
defined culture medium for physiological studies
(5), prompted this genetic study of sulfonamide-
resistant clinical isolates of N. meningitidis and
N. gonorrhoeae. The resistance of strains of both
species could be introduced by transforming
deoxyribonucleate (DNA) preparations into the
sulfonamide-susceptible recipient, N. meningitidis
strain Ne 15. Two classes of sulfonamide resis-
tance could be distinguished by transformation.
Resistance of one class was not associated with
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significant nutritional change, whereas that of the
other was invariably associated with a require-
ment for methionine.
Numerous studies have been made of the anti-
bacterial action of sulfonamides and of the
development of bacterial resistance (19). The
discovery by Woods (40) that sulfonamide com-
petitively inhibits bacterial utilization ofp-amino-
benzoic acid (PAB) was followed by the recogni-
tion that PAB is an essential component of folic
acid. Folic acid coenzymes function as carriers
of single carbon units in the biosynthesis of
methionine and several other amino acids, and
also of purines and thymine. Thus, the bacterio-
static action of sulfonamide is due to the ultimate
shortage of the essential end products of folic acid
metabolism (41). This explains the latent period
that is observed before sulfonamide measurably
reduces the rate of bacterial growth (23).
Various factors enhance the capacity of a
given bacterial strain to multiply in the presence
of a concentration of sulfonamide higher than the
minimal inhibitory concentration established for
that strain under standard conditions. These may
be grouped into two categories depending on
whether genetic change is or is not associated
with the increased resistance: phenotypic resis-
tance and genetic resistance.
In the absence of any genetic change (pheno-
typic resistance), the bacteriostatic action of sul-
fonamide is reduced by exogenous supplementa-
tion of the bacterial environment with PAB (40)
or with one or more of the essential products of
folate metabolism (41). Thus, methionine was
shown to be an antagonist of sulfonamide for
Escherichia coli (15); moreover, the methionine
biosynthetic pathway was recognized as being
the most sensitive to inhibition by sulfonamides
(38).
Genetic changes resulting in increased endog-
enous supplies of PAB (24, 40), or in alteration
of a PAB-utilizing enzyme with consequent de-
creased affinity for sulfonamides (7, 17), were
proposed to account for increased resistance.
Recent work with two cell-free systems has shown
that enzymes which catalyze the formation of
folate compounds from PAB indeed do differ
structurally: those extracted from sulfonamide-
resistant mutants combine with sulfonamide less
readily than do the corresponding enzymes ex-
tracted from the original parent bacteria (30, 39).
Furthermore, a genetic parallel to the end-product
antagonism of sulfonamide bacteriostasis is found
in certain mutational events that impose a nutri-
tional requirement for methionine. It will be
shown that N. meningitidis clones, which are un-
able to perform this folate-catalyzed biosynthetic
reaction because of a genetic block introduced
by spontaneous mutation or by transformation,
are able to multiply in a defined medium con-
taining methionine together with sulfadiazine at a
concentration higher than that sufficient to in-
hibit growth of the parental strain in the same
methionine-containing medium.
MATERIALS AND METHODS
Chemicals. Inorganic chemicals and PAB were
certified reagent grade obtained from Fisher Scientific
Co., Pittsburgh, Pa. Crystalline vitamin B12 was from
Sigma Chemical Co. (St. Louis, Mo.). Calbiochem
(Los Angeles, Calif.) supplied the S-adenosyl-L-
methionine (B grade) and all amino acids (A grade,
"chromatographically homogeneous") except DL-
homocysteine free base (Nutritional Biochemicals
Corp., Cleveland, Ohio). Homocysteine also was
prepared immediately before use from L-homocysteine
thiolactone hydrochloride (A grade, Calbiochem) by
addition of alkali by two slightly different methods
(11, 16). L-Homocystine ("chromatographically
homogeneous"), found to be contaminated with
methionine, was recrystallized from a solution in hot
sodium acetate buffer (0.05 M, pH 6). Crystalline di-
hydrostreptomycin sulfate (USP; E. R. Squibb &
Sons, New Brunswick, N.J.) and sodium sulfadiazine
(solution, 0.25 g/ml; Lederle Laboratories, Pearl
River, N.Y.) were the antibacterial agents used.
Crystalline pancreatic deoxyribonuclease (sterile;
Worthington Biochemical Corp., Freehold, N.J.) was
used to destroy activity of transforming DNA.
Media. The complex medium (HIY-1) used rou-
tinely for growth and transformation tests of N.
meningitidis Ne 15 has been described (2). It contains
Difco Heart Infusion Broth, Yeast Extract, and
Bacto-agar (1.4%, w/v, for hard agar and 0.7% for
soft agar), together with calcium and other supple-
ments.
N. gonorrhoeae was cultivated (35 C with 5 to 10%
C02) on chocolate-agar prepared with Proteose No. 3
Agar (Difco) and 5% sheep blood.
The defined medium was prepared by methods
detailed previously (5). The components of solutions
A and B (mineral salts), and D (sodium lactate), were
the same as before, but other components were
changed. As the sodium glutamate employed earlier
was found to be contaminated with methionine (a
difficulty also encountered by others (9, 27), glutamic
acid was used (final concentration, 8.0 mM). The
sodium salt was prepared by slow addition of 2 N
sodium hydroxide (to the 400 mm stock) to give pH
7.4. Serine was routinely added at a concentration of
0.2 mM; though not required, it promoted growth in
defined fluid of some transformants (Sul-r Met+).
The remaining components of the routine medium
were arginine (0.5 mM), glycine (2.0 mM), calcium
chloride (0.2 mM), ferric sulfate (0.01 mM), and glyc-
erine (0.5%, v/v). As emphasized before (5), the pH
of the final medium must be rigidly controlled (7.4 i
0.1) in order to obtain growth of N. meningitidis from
small inocula. To avoid pH changes associated with
autoclaving, the various stock solutions (except CaCl2,
glycerine, and agar) were sterilized separately by
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filtration (HA membranes; Millipore Corp., Bedford,
Mass.) and combined aseptically. The complete
medium without agar is referred to as defined fluid.
"Hard" and "soft" agar medium contained, respec-
tively, 1.0 and 0.5% (w/v) Purified agar (Difco).
Defined agar was supplemented with amino acids
and other substances for special studies. When solubil-
ity of the compound permitted, a stock solution (100
to 1,000 times the required concentration) was pre-
pared, filter-sterilized, and added aseptically. Diffi-
cultly soluble (cystine, homocystine) or expensive
(adenosylmethionine) compounds were weighed
aseptically and added directly to the prepared sterile
medium; contaminant colonies were rarely observed.
Abbreviations. Until the precise mechanism relating
the methionine requirement and sulfonamide resist-
ance of Neisseria is established, it is convenient to
indicate the various genetic changes which affect the
test strain N. meningitidis Ne 15 in terms of their
recognized phenotypic effects. In concordance with
recent recommendations (10), the following pheno-
typic abbreviations will be used. Sul-r20 Met+ will
refer to mutant strains or transformants which are
able to produce colonies on HIY-1 agar containing
suifadiazine at a concentration of 20 ,g/ml, but not
at 100 ,g/ml, and which do not show a nutritional
requirement for methionine in defined medium. Sul-r
Met+ indicates strains that produce fast-growing
colonies on 100 Mg of sulfadiazine per ml, and do not
require methionine. Sul-r/Met- will refer to strains
which reproduce on sulfadiazine-containing agar more
slowly and require methionine for growth in defined
medium; the two characteristics are acquired con-
currently during transformation. Str-r will refer to
strains which are resistant to dihydrostreptomycin
(DHS) incorporated in HIY-1 agar at a concentration
of 500,g/mI.
DNA donor strains. Strains of N. meninigitidis and
N. gonorrhoeae which were resistant to sulfadiazine
when isolated from clinical material were received
from other laboratories (Table 1). The four meningo-
coccal strains were all serological group B, as were the
streptomycin-resistant mutants derived from them.
Methods used at Statens Seruminstitut to isolate and
identify gonococci, and results of susceptibility studies,
have been published (31, 32). To simplify the presenta-
tion and discussion of transformation results, roman
numerals will be used to designate DNA preparations
from these clinical isolates.
DNA preparations I-VI were obtained from Str-r
strains. The Str-r mutants of N. meningitidis were
derived by the method previously described (4). N.
gonorrhoeae 1197/61 was resistant to DHS as well as
to sulfadiazine when isolated. N. gonorrhoeae 7764/45
Str-r was obtained by selecting an isolated mutant
colony which grew on heavily inoculated chocolate-
agar containing 500 ,g of DHS/ml. The str gene
provided a valuable reference marker for work with
these six transforming DNA preparations. DNA
preparations VII-XI, on the other hand, did not bear
this marker. These gonococcal strains were cultivated
on drug-free chocolate-agar exclusively. After revival
from the lyophilized state, they were subcultured only
the several times required to establish their purity
and to obtain physiologically active cells for extraction
of DNA. This precaution was taken to avoid the
possibility of selecting nutritionally deficient strains.
DNA preparations, which were used for reference
purposes in many tests, were obtained from two differ-
ent sulfadiazine-resistant strains derived in vitro from
the wild-type N. meningitidis Ne 15. Ne 15 (Sul-r I)
Met- Str-r had a mixed origin. A Sul-r transformant
colony, obtained by treating Ne 15 with DNA I,
was picked from HIY-1 agar containing 50 ,Ag of
TABLE 1. Sources of the Neisseria strains, resistant to sulfadiazine upon primary isolation, from which
transforming deoxyribonucleate preparations were obtained
Species Strain Source Year isolated Str-r Designationfor DNA
N. meningitidis NM-131a Spinal fluid 1963 Me I
64-84a Spinal fluid 1964 M If
64-129a Blood 1964 M III
28988b Blood 1965 M IV
N. gonorrhoeae 1197/61b UDc 1961 PIf V
7764/45b UD 1945 M VI
W 18b UD 1946 No VII
W 58b UD 1946 No VIIl
18000b UD, Spd 1940 No IX
18273b UD, SP 1940 No X
31956b UD 1941 No Xi
a Strain (18) received from D. Ivler.
bStrain received from A. Reyn, Statens Seruminstitut, Copenhagen, Denmark.
c Discharge from male urethra.
d Separate isolations from the same patient.
e Mutant obtained in vitro; resistant to 500 ,ug of dihydrostreptomycin per ml.
f Primary isolate was resistant to 2 mg of dihydrostreptomycin per ml.
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sulfadiazine/mi; it was resistant to 200 pug as revealed
by equal growth on agar containing 100, 150, and
200 pg of sulfadiazine per ml. A mutant colony ob-
tained by growth at 300 ,g of sulfadiazine per ml was
subcultured on higher concentrations. A single colony
capable of growth on 500 pg of sulfadiazine per ml
was isolated, and a Str-r clone was obtained from it.
The DNA preparation was obtained from cells which
had been subjected repeatedly to single-colony isola-
tion, thereby minimizing the possibility that a mixed
culture was used. Nevertheless, subsequent tests of
its transforming activity (e.g., test 10, Table 2) re-
vealed two kinds of sulfadiazine-resistant transform-
ants, Sul-r Met+ and Sul-r/Met--. Standard practice
involves freezing (at -60 C) a sample of the inoculum
used for all DNA cultures. Therefore, it was possible
(a year later) to examine the culture on defined agar.
The total population was found to be composed of
methionine-requiring cells.
Ne 15 Sul-r/Met- Str-r 64 was obtained by sequen-
tial selections of isolated mutant colonies from cultures
on HIY-I agar containing increasing concentrations of
sulfadiazine, each culture incubated for 2 days at 35 C
in humidified air atmosphere. The first mutation in
the sequence conferred resistance to 100 pg of sulfadia-
zine per ml. A number of subsequent mutations oc-
curred during growth on 150, 250, 400, and finally
500 pg of sulfadiazine per ml. Lastly, a Str-r clone was
selected.
In the same manner, a multistep sulfadiazine-
resistant strain was obtained from N. perflava Ne
16. The final mutant colony was selected by use of 250
pug of sulfadiazine per ml. It proved to be Sul-r/Met.
Transforming DNA. N. meningitidis strains were
cultivated in HIY-1 broth containing half the con-
centration of sulfadiazine and DHS to which the
strain was resistant. After 16 to 20 hr of incubation
(with shaking in air at 35 C), cells were harvested by
centrifugation, suspended in a solution containing
NaCl (0.15 M) and sodium citrate (0.015 M), and fro-
zen. N. gonorrhoeae strains were cultivated on drug-
free chocolate-agar, petri dishes being incubated at
35 C in candle jars, or in a CO2 incubator with 10%
CO2 when large dishes were used to obtain more cells.
Growth was removed from agar with NaCI-citrate
solution, washed once by centrifugation, and frozen.
Rapid lysis of the thawed cell suspensions was ob-
tained with 0.5 to 1.0% sodium dodecyl sulfate. DNA
was extracted and partially purified (3).
Transformation. For streptomycin resistance, the
method described previously (2, 4) for quantitative
transformation of N. meningitidis Ne 15 was used,
except that soft agar inoculated with a sample of the
reaction mixture was overlaid in 4-ml volumes on
five plates of antibiotic-free agar. These plates were
incubated at 35 C until removed for addition of a 6-ml
layer of HIY-1 soft agar containing DHS sufficient to
give a final concentration of 500 ,ug/ml after diffusing
throughout the agar. This challenge dose of antibiotic
was added 5 hr after the time of mixing recipient
bacteria with DNA, the intervening period having
been found optimal for phenotypic expression of
resistance to DHS.
For sulfadiazine resistance, only slight modification
ofthe test method was required. Phenotypic expression
of resistance to sulfadiazine did not require prolonged
incubation in drug-free medium, but occurred in
SULF agar during the time that the intracellular
concentration of critical metabolic products was being
depleted (23, 41). A sample of the recipient cell plus
DNA reaction mixture was added to HIY-l soft agar
containing sulfadiazine and was overlaid in 5-ml
volumes on five plates of hard agar of similar com-
position. Cultures were incubated (35 C, humidified
air atmosphere) for 3 to 6 days before colonies were
counted, growth of Sul-r/Met- transformants being
much slower than Sul-r Met+ on media containing
100 pug and especially 200 pug of sulfadiazine per ml.
The lowest concentration of sulfadiazine, 20 pg/ml,
used routinely in transformation tests was selected
after considerable preliminary study. Colony forma-
tion by the recipient strain Ne 15 on HIY-1 agar was
partially inhibited at a concentration of 5 pAg of sul-
fadiazine per ml, the number inhibited being inversely
related to population size. Bacteriostasis was nearly
complete at 10 pug/mi, but the fraction of Sul-r mu-
tants was unduly high. Even in 20 ,pg of sulfadiazine
per ml, spontaneons mutants were always encountered.
To determine their number accurately, a control
reaction mixture (recipient cells plus deoxyribonu-
clease-inactivated DNA) was incubated and sampled
in parallel with the transformation tests. In calculating
percentage transformation, the number of mutant
colonies was subtracted from the number of colonies
on transformant plates at corresponding sulfadiazine
concentrations. The percentage of spontaneous mu-
tants on sulfadiazine (20 ,g/ml)-agar commonly
ranged from 0.001 to 0.0004, and on sulfadiazine
(100 pg/ml)-agar from 0.0003 to 0.00005. Mutant
colonies were never observed on sulfadiazine (200
pg/ml) control plates. Of 41 spontaneous mutants
picked from sulfadiazine (20 pg/ml)-agar of one
control test, 13 were Met+ and 28 were Met-; all of
33 colonies from agar containing l00pg of sulfadiazine
per ml were Met-.
The method for assay of total colony-forming units,
details concerning the recipient cell plus DNA reac-
tion mixture, and various precautions have been de-
scribed before (2-4).
Transformation to prototrophy of methionine-
requiring strains was examined by use of defined
medium. Met- recipient cells were grown for 12 to 14
hr on agar medium, usually defined agar supplemented
with 0.05 mm methionine, or occasionally HIY-1 agar.
Cells were removed with a loop and suspended in
defined fluid, prewarmed to 35 C. Equal volumes of
cellular suspension (with no intervening incubation)
and transforming DNA (diluted in defined fluid) were
mixed and allowed to react at 35 C for 20 to 30 min.
Met+ transformants were assayed by alternative
methods. Method A provided more quantitative re-
sults, but was more time-consuming. Deoxyribonu-
clease was added to terminate uptake of DNA. A
sample of the reaction mixture was added to 20 ml of
methionine-free defined soft agar at 44 C, which was
immediately overlaid in 5-ml volumes on four defined
hard agar plates. Method B, which gave only semi-
quantitative results, was used to expedite sampling of
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larger numbers of reaction mixtures. For this, deoxyri-
bonuclease was not added. Single samples (0.05 ml)
of each reaction mixture were spread over the sur-
faces of methionine-free defined hard agar plates, with
the aid of sterile bent glass rods. A deoxyribonuclease-
inactivated DNA control reaction mixture was in-
cluded in experiments with every recipient suspension.
For determination of the total number of treated cells
(expressed as colony-forming units), dilutions in de-
fined fluid were plated in triplicate (by the overlay
method) in defined agar containing 0.1 mm methio-
nine.
Replica plating. Cells from a DNA reaction mix-
ture, suitably diluted, were spread with a sterile glass
rod over the surface ofHIY-1 agar containing 20 ,g of
sulfadiazine per ml. After incubation (35 C, 20 to
40 hr), the transformant colonies on this "master"
plate were sampled by pressing gently against sterile
velvet stretched over a flat circular form. Cells were
transferred, by similar pressure, from the velvet to
the surfaces of as many as eight sterile agar media.
Faithful replicas of colonies on the "master" plate
were obtained by using damp velvet cloth (circles in
large petri dishes were autoclaved within a few hours
of use) and agar plates which had been judiciously
dried (retained at room temperature long enough to
eliminate subsequent development of surface mois-
ture, which displaces the cells, but not so long as to
become wrinkled, a deterrent to growth).
PAB. Two methods were used to determine the
concentration of PAB or compounds having PAB-
equivalent activity. The first employed PAB Assay
Medium (Difco) with slight modification of the
method described (Difoc Supplementary Literature,
Difco Laboratories, Detroit, Mich.). Stock strains of
Acetobacter suboxydans ATCC 621 exhibited fila-
mentous cells and flocculent growth which tended to
adhere to glass. More homogeneous growth was
obtained in the assay medium by using a small inocu-
lum of cells selected from smooth colonies. Cultures
(10-ml volumes aseptically distributed in 125-ml screw-
cap flasks) were shaken continuously during incuba-
tion (30 C, 60 hr). Readings of optical density were
made at 650 m,u (Spectronic-20 colorimeter) after
diluting each culture with an equal volume of water
and mixing thoroughly. Characteristics of this assay
system (e.g., appreciable growth in the absence of
added PAB) were such as to make quantitative aspects
of the test dubious (22).
Therefore, an independent method was devised to
compare the sulfadiazine-antagonizing activities of
defined culture filtrates from various strains of N.
meningitidis. For this, defined agar with Fisher gluta-
mate (5) containing 0.6 ,ug of sulfadiazine per ml was
pipetted aseptically in 20-ml volumes into flat-bottom
Pyrex petri dishes. Left overnight at room tempera-
ture, the agar became dry enough to accept a 4-ml
overlay of soft defined agar (with sulfadiazine, 0.6
ug/ml, and an inoculum of N. meningitidis Ne 15 Sul-s
cells, 105 to 106/ml) without subsequent development
of surface moisture. Sterile discs (diameter, 6.5 mm),
punched from absorbent Millipore filter support pads,
were saturated with test fluid and dropped on the
solidified inoculated agar. Culture filtrates were tested
in duplicate, and PAB standard solutions (diluted in
defined fluid) were tested in triplicate at concentra-
tions of 4, 2, and 1 gg of PAB/ml. Growth of the
meningococcus was inhibited by the sulfadiazine ex-
cept in zones peripheral to the discs where sulfadiazine
antagonizing compounds had diffused. Zones were
clearly defined and their diameters measurable after
incubation at 35 C for 2 days. A linear relationship
was found between the mean response and the loga-
rithm of PAB concentration.
Cross-resistance. Sulfadiazine was the only sulfon-
amideexamined in quantitative tests. However, qualita-
tive tests were performed to determine whether resist-
ance of the N. meningitidis strains applied to other
sulfonamides as well. HIY-1 agar was used: 20-ml
bottom layers and 3-ml overlays of soft agar inocu-
lated with not more than 106 cells from a 16- to 18-hr
HIY-1 agar culture. Commercially available paper
discs (generously provided by BBL) containing 0.25
mg of each compound were placed on the solidified
agar. Plates, after incubation for 24 hr, were examined
for significant inhibition of bacterial growth (zones
with a radius greater than 1 mm) peripheral to the
discs. The meningococcal strain Ne 15 used as recipi-
ent in transformation tests was susceptible to the
following compounds: (a) sulfadiazine, (b) sulfathia-
zole, (c) sulfamerazine, (d) sulfisoxazole, (e) sulfisomi-
dine, (f) sulfamethoxypyridazine, (g) sulfachloropyrid-
azine, (h) 2,4-dimethoxy-6-sulfanilamido-1,3-diazine,
(i) sulfamethylthiadiazole, (j) sulfaethylthiadiazole.
Strains 64-84, 64-129, and NM-131 were insus-
ceptible to compounds a-g and susceptible to com-
pounds h-j. Transformant clones picked from HIY-1
agar containing 200 ,ug of sulfadiazine per ml showed
similar patterns of resistance, except that some re-
mained susceptible to compound g.
RESULTS
Sulfadiazine resistance transformation frequen-
cies. DNA preparations from a variety of sulfadi-
azine-resistant strains of Neisseria had trans-
forming activity for the sulfadiazine-susceptible
meningococcal strain Ne 15 (Table 2). Genetic
information which evoked resistance to 20 ug of
sulfadiazine per ml or to 500 ,4g of DHS/ml
(reference marker) was introduced separately but
at frequencies which did not differ greatly, except
for the DNA examined in test 10. This DNA
produced twice as many transformants resistant
to sulfadiazine (20 ,g/ml) as to DHS, owing to
the fact (established by replica plating, and dis-
cussed below) that two different kinds of trans-
formant colonies were being counted on agar con-
taining 20 Mg of sulfadiazine per ml.
DNA preparations from N. gonorrhoeae and N.
perflava elicited transformations at lower fre-
quencies than those typical of N. meningitidis
DNA, as expected of inter-specific transforma-
tion (3).
The sulfadiazine resistance of DNA donor
strains could be inferred in relative terms from the
VOL. 94, 1967 723
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TABLE 2. Trantsformationis of Neisseria menintgitidis Ne 15 by DNA from various Neisseriaa
Transformation (%)
Test no. DNA prepnb Resistance to sulfadiazine Resistance
-toDHS
20 pg/ml 50 ug/mi 100 pg/ml 200 pg/ml (500 pig/ml)
1 N. meninlgitidis, 1 0.196 0.165 0.167 0.152 0.156
2 N. meningitidis, II 0.197 0.158 0.141 0.138 0.134
3 N. meningitidis, III 0.224 0.181 0.180 0.172 0.187
4 N. menin1gitidis, IV 0.213 0.161 0.153 0.154 0.137
S N. goniorrhoeae, V 0.037 0.0024 <0.00001 <0.00001 0.039
6 N. gonorrhoeae, VI 0.039 0.033 0.030 0.002 0.042
7 N. meniiiigitidis Ne 15 Sul-r20 0.169 0.157 <0.00001 <0.00001 SDc
Met+16
8 N. meniligitidis Ne 15 Sul-r/Met- 0.280 0.236 0.230 0.003 0.271
Str-r 64
9 N. perflava Ne 16 Sul-r/Met- Str-r 0.013 0.011 0.010 (no test) 0.021
10 N. meninigitidis (Sul-r I) Met- Str-r 0.327 0.309 0.291 0.134 0.176
Reaction mixtures in HI-I broth contained recipient cells (suspension prepared from 12-hr HIY-1
agar culture) with 5.0,ug of DNA/ml. Reaction at 35 C was terminated by deoxyribonuclease after 30 min.
A single recipient cell suspension, 7.1 X 106 colony-forming units/ml was used for tests 1-8; 9 and 10
were separate.
b Details, Table 1.
c DNA donor strain and transformants (0.056%) were streptomycin-dependent (2).
transformation frequencies. Thus, the four N.
meningitidis clinical isolates possessed the genetic
potential for resistance to 200 ,ug of sulfadiazine
per ml, as shown by the transforming activities of
their DNA (I-IV). Three of the strains had been
recorded (18) as having this degree of phenotypic
resistance, and, indeed, all four were capable of
growth on HIY-1 agar containing 200 Ag of
sulfadiazine per ml.
In comparison, the two N. gonorrhoeae strains
were revealed as having greater and unequal
susceptibility. DNA VI evoked resistance to 20
and 100 Mg of sulfadiazine per ml at nearly the
same frequencies, but to 200 ,g/ml at a lower
frequency. DNA V evoked resistance to 20 ,g of
sulfadiazine per ml at a frequency similar to that
of DNA VI. However, DNA V transformants
formed colonies only rarely on agar containing
100,g of sulfadiazine, and never on agar with
200 Mg of sulfadiazine per ml. The degree of
resistance of the gonococci themselves could not
be determined on the same medium because of
inadequate growth. However, introduction of the
relevant genes into the uniform genetic back-
ground of Ne 15 resulted in Sul-r transformants
which clearly differed from those produced by
DNA preparations I-IV. A further difference was
reflected in the smaller size of DNA VI trans-
formant colonies on agar containing 100 Mg of
sulfadiazine per ml after incubation for 2 days.
On agar with 200 Mug of sulfadiazine per ml, they
were barely visible in 2 days, and tended to remain
very small even after a 6-day incubation. They
were counted as transformants, however, be-
cause no colonies were ever detected on corre-
sponding control plates (i.e., agar containing 200
Mg of sulfadiazine per ml inoculated with cells
treated with deoxyribonuclease-inactivated DNA).
This growth characteristic of the DNA VI trans-
formants could not be attributed merely to the
fact that the genetic factor originated in N.
gonorrhoeae, as comparable transformants also
were produced by the DNA preparations ex-
amined in tests 8 and 9.
Replica plating. The transformants elicited by
the DNA examined in test 10 (Table 2) were of
two types. One formed small colonies on
agar containing 100 Mg of sulfadiazine per ml,
like those of tests 6, 8, and 9. Colonies of the
other type were large, like DNA I transformants.
The sulfadiazine resistance of the DNA-donor
strain itself was of mixed origin: resistance in-
troduced into Ne 15 by transformation with
DNA I, and additional resistance obtained by
spontaneous mutation. Replica plating of trans-
formant colonies which had grown on agar con-
taining 20 Mg of sulfadiazine per ml revealed a
nutritional difference. The type which produced
small colonies on agar containing sulfadiazine
was invariably methionine-requiring (Fig. 1-7).
Methionine-free defined agar (Fig. 1) supported
growth of the large colonies only. Visible but
limited growth of the small type occurred on
defined agar containing 0.005 mm methionine
724 CATLIN J. BACTERIOL .
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FIG. 1-12. Suilfadiazine-resistant transformant colonies on various media, incubated for 2 days. Figures 1-7
are correspondinig areas of replica plates made in the order giveni from a sinigle sulfadiazine (20 /2g/m[) transforma-
tion plate (not showni) from test 10, Table 2; Fig. 8-12 are a series of replicas from a single transformation plate(20 tig/ml; n-ot showni) from test 6, Table 2. Growth responses of cells from identical clones can be compared on de-
fined agar lackinig methioninie (Fig. 1) or with methioninie at concentrations of 0.005 mmi (Fig. 2, 8), 0.05 mm (Fig.
3), 0.1 mmi (Fig. 4, 9); HIY-1 agar with 100 mg ofsulfadiazine per ml (Fig. 5, 10), with 20 pAg/ml (Fi. 6, 11), or
sulfadiazine-free (Fig. 7, 12). Photographs are noz magnzified and nol retouched.
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(Fig. 2). Progressively higher concentrations of
methionine (0.05 mm, Fig. 3; 0.1 mm, Fig. 4)
promoted proportionally better growth of these
colonies. Their growth after 2-day incubation on
HIY-1 agar with 100 ,g of sulfadiazine per ml
(Fig. 5), as expected, was less than on 20 ,g/ml
(Fig. 6) or on drug-free agar (replicated last,
Fig. 7). The methionine content of HIY-1 agar
was sufficient for optimal growth of the me-
thionine-requiring transformants in the absence
of sulfadiazine. Thus, when growth on HIY-1
agar was initiated from isolated cells, Sul-r Met+
colonies and Sul-r/Met- colonies were indis-
tinguishable. Differences observed in Fig. 7 re-
flect the differing size of the original transformant
colonies on the sulfadiazine (20 Ag/ml) "master"
plate, the velvet pile design being due to the
relatively dry agar which restricted growth.
The transformant colonies produced by gono-
coccal DNA VI (test 6, Table 2) were shown by
replica plating to be all of the methionine-requir-
ing type. Their response to methionine was the
same as that of other Sul-r/Met- transformants,
as to degree of growth on the defined agar supple-
mented with low concentrations of methionine
(0.005 mm, compare Fig. 8 with Fig. 2), and
optimal growth at a concentration of 0.1 mM
(Fig. 4, 9). Various transformant clones differed
somewhat in their capacity to tolerate sulfadia-
zine, as revealed by the decreased number of
transformants with increased concentration. An
example is provided by the colony, located close
to the numeral in Fig. 12, which produced no
growth on 100 Mug of sulfadiazine per ml (Fig. 10)
and only limited growth on 20 mg/ml (Fig. 11)
during the 2-day incubation period.
A few Met+ papillae appeared on Met- colo-
nies on defined agar containing low concentra-
tions of methionine (Fig. 8). Very few occurred
on methionine-free agar, and they were present
only rarely at corresponding sites on companion
replica cultures. The replica-plating technique
(25) thus established that they originated as
separate events occurring after the bacteria were
deposited on the replica agar. If a genetic event
leading to production of the Sul-r Met+ pheno-
type had occurred in the DNA reaction mixture,
the colony produced on the sulfadiazine-agar
"master" plate must be wholly Met+. Therefore,
Met+ clones must appear on all methionine-
deficient agar replicas at a topographically identi-
cal site.
These criteria were fulfilled for Sul-r trans-
formants obtained with DNA V. Hundreds of
colonies were examined by replica plating and all
were Met+. Similarly, the transformants obtained
in test 7 (Table 2) were Met+. This DNA, ob-
tained to serve as a model for comparison with
DNA V, was from a spontaneous mutant (iso-
lated from Ne 15) which was resistrnt to 20 Mg
of sulfadiazine per ml, susceptible to 100 Mg/ml,
and Met+. It resembled DNA V except with re-
spect to the ratio of Sul-r50 to Sul-r20 transfor-
mants.
In summary, transformants of tests 1-4 (Table
2) were highly resistant to sulfadiazine and ex-
hibited no added nutritional requirements (Met+).
Those of tests 5 and 7 showed only a limited
increase in sulfadiazine resistance, and were
Met+. Transformant colonies of tests 6, 8, and 9
were Met-, and, though moderately resistant,
were characterized by a tendency for small size
on elevated concentrations of sulfadiazine.
PAB production. Many investigators have
found that PAB is synthesized in larger amounts
by some sulfonamide-resistant clinical isolates
than by susceptible strains of the same bacterial
species. The availability of additional PAB either
inside or outside the cells acts at the phenotypic
level to decrease bacterial susceptibility to sul-
fonamides, as mentioned previously. It is ques-
tionable, however, whether the two to five times
higher concentrations of PAB reported for Neis-
seria (18, 24) provide the genetic basis for 200
times greater sulfonamide resistance. This
question can be examined critically by trans-
formation. As relatively short nucleotide se-
quences appear to be integrated typically in
transformation, only limited genetic information
is introduced into the genome of the recipient cell.
Physiological differences between the Sul-s recip-
ient strain and the Sul-r transformants, therefore,
should be restricted to those directly associated
with the resistance.
Strain Ne 15 and various transformant clones
(isolated colonies picked from agar containing 20
,Mg of sulfadiazine per ml in tests similar to those
of Table 2) were cultivated in defined fluid (with
0.05 mM methionine, if required). The cultures
(25-ml volumes in 500-ml flasks), incubated in air
at 35 C on a rotary shaker, were examined period-
ically for 3 days. Population densities of 3 x 109
to 6 X 109 colony-forming units/ml were at-
tained within 36 hr. Thereafter, viability declined
and considerable autolysis occurred. The concen-
tration of PAB (or compounds that could replace
it as growth factor for A. suboxydans) increased
progressively during the 3-day incubation (sam-
ples sterilized by Millipore membrane filtration).
For cultures of the same age and population den-
sity, PAB-equivalent concentration differed by
less than a factor of 2.
The possibility remained, however, that the
values determined on filtrates might not represent
total cellular PAB. As PAB is heat-stable (24, 40),
62-hr cultures were subjected to heat extraction
(121 C, 10 min). The supernatant fluids were as-
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sayed by two methods: (i) growth stimulation for
A. suboxydans, and (ii) sulfadiazine-antagonizing
activity (disc test). Again, differences between cul-
tures were not greater than twofold, although
method ii apparently determined compounds
additional to those which possessed growth-
promoting activity in i. Values obtained for the
Sul-s strain Ne 15, expressed as micrograms of
PAB equivalents per milliliter, were 0.43 by
method i and 2.5 by method ii. Corresponding
values for six Sul-r transformant clones (picked
from agar containing 20 ,ug of sulfadiazine per
ml of tests, as enumerated in Table 2) were: no. 1,
0.43, 3.2; no. 2, 0.35, 3.0; no. 3, 0.52, 3.5; no. 5,
0.42, 2.5; no. 7, 0.42, 2.5; no. 9, 0.5 and 5.1. Al-
though quantitative aspects of both methods are
open to criticism, the assays should have detected
gross differences of PAB or of compounds having
sulfadiazine-antagonizing activity, had such dif-
ferences existed.
The conclusion appears justified, therefore, that
PAB production of recipient strain Ne 15 is not
significantly affected when these sulfonamide
resistance factors are introduced by transforma-
tion.
Gonococci of the sulfonamide era. Trans-
formants elicited by DNA from a gonococcal
strain (7764/45) isolated in Denmark during the
period of therapeutic use of sulfathiazole (31)
differed nutritionally from those obtained with
DNA from a more recent isolate (1197/61). It
was of great interest, therefore, to examine five
additional Danish strains of sulfathiazole-resist-
ant N. gonorrhoeae (Table 1) which also had been
isolated during the sulfonamide era. Retained in
the lyophilized state during the intervening years,
these strains were received after the nutritional
difference between Sul-r transformants was rec-
ognized. Therefore, precautions were taken to
avoid laboratory manipulations which might affect
the genetic constitution of these gonococci. They
were cultivated on drug-free chocolate-agar ex-
clusively; only a few subcultures were made, and
these were initiated from a considerable number
of typical colonies.
Transforming activities of DNA preparations
from all the strains of N. gonorrhoeae were deter-
mined, and transformant colonies which de-
veloped on sulfadiazine (20 Ag/ml) -agar (300 or
more for each DNA) were examined by replica
plating. The frequencies of transformation ob-
tained with DNA preparations VI-XI were not
all alike (Table 3), and different degrees of resist-
ance were elicited. Nevertheless, the transform-
ants obtained were uniformly methionine-requir-
ing. A few Met+ colonies were present on trans-
formation plates containing sulfadiazine (20
,ug/mI) -agar, but their number was not greater
than the number of Sul-r Met+ spontaneous
TABLE 3. Tranisformation of Neisseria meningitidis
Ne 15 by DNA from N. gonorrhoeaea
Transformation (%) of resistance to sulfadiazine
DNA
prepnb
20 jAg/ml 100 ,Ag/mI 150 ug/ml 200 ,ug/ml
VI 0.0492 0.0402 0.0212 0.0009
VII 0.0613 0.0499 0.0237 0.00022
VIII 0.0024 0.0018 0.0016 0.00002
IX 0.0060 0.0041 0.0035 0.00008
X 0.0071 0.0040 0.0026 0.00009
XI 0.0438 <0.000005 <0.000005 <0.000005
Vc 0.0380 <0.000005 <0.000005 <0.000005
a Reaction mixtures in HI-I broth contained
recipient cells (2.0 X 107 colony-forming units/
ml; suspension prepared from 12-hr HIY-1 agar
culture) with 10.0 ,g of DNA/ml. Reaction at
35 C was terminated by deoxyribonuclease after
20 min.
b Details, Table 1.
c Str-r transformation (0.032%) obtained in
this test.
mutants, which were found on corresponding
control plates spread with cells treated with
deoxyribonuclease-inactivated DNA. Transfor-
mants of DNA V, examined for control pur-
poses, were Met+ as before. The tests did not
show mixtures of Met- and Met+, and thus
failed to reveal different mechanisms of resistance,
such as were found for the DNA donor strain
examined in test 10 (Table 2). It was inferred,
therefore, that resistance of all six gonococcal
strains isolated during the period 1940-1946 was
exclusively of the type Sul-r/Met-.
Examination of Sul-r/Met- strains of Ne 15.
Results described for this class of transformants
suggested that the two phenotypic properties,
sulfonamide resistance and requirement for me-
thionine, were acquired concurrently. To obtain
insight into the relationship, various Sul-r/Met-
strains were examined to determine which step in
the biosynthetic pathway was affected. Also, the
Met- strains were used as recipients in trans-
formation tests to see whether their biosynthetic
defects could be corrected by genetic information
derived from various other Met- strains. Re-
covery of Met+ transformants in such crosses
testified to the nonidentity of the genetic altera-
tions underlying the methionine requirement.
Furthermore, the Met+ transformants so ob-
tained were tested on sulfadiazine-agar to
determine whether loss of the methionine require-
ment was accompanied by loss of resistance.
Growth response to methionine and possible
precursors. Methionine biosynthesis by various
members of Enterobacteriaceae involves a series of
reactions leading from homoserine and cysteine
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to cystathionine. Cleavage of cystathionine yields
homocysteine. Three genetic loci govern the
structures of three enzymes which catalyze these
reactions. Mutations affecting any of these loci
result in a nutritional requirement for methionine,
which can be replaced by homocysteine (14, 20,
36). The final reaction of the biosynthetic se-
quence involves the methylation of homocysteine
to yield methionine. This step in E. coli and
Salmonella typhimurium is a complex one which
involves methyltetrahydrofolates as the imme-
diate sources of the transferred methyl group (6).
Auxotrophic mutants blocked in the performance
of the terminal step show a methionine require-
ment which cannot be replaced by any of the
previous compounds in the series (6, 14, 36).
The following Sul-r/Met- transformants of Ne
15 were tested: isolates from sulfadiazine (20
Ag/ml)-agar of tests 8, 9, 10 (Table 2), and from
tests with DNA VI (isolates g2, g52), VII (g54),
VIII (g22), IX (g7), X (g55), and XI (g58). Also,
six Ne 15 Sul-r/Met- spontaneous mutants were
examined: Ml, M33, M54, M58, M61, M69. Si-
multaneous tests were run with the parent strain
to reveal possible growth inhibition by the various
compounds. Light suspensions in defined fluid
were streaked on defined agar separately supple-
mented with L-methionine (5.0 to 0.0005 mM),
L-homoserine (0.5,0.05 mM), L-cysteine (0.5, 0.05
mM), DL + allo cystathionine (0.5, 0.05 mM), L-
homocysteine (0.5, 0.2, 0.1, 0.05 mM), L-homo-
cystine (0.5 to 0.02 mM), L cystine (0.5, 0.05 mM),
vitamin B12 (0.005, 0.00005 mM), or S-adenosyl-
L-methionine (0.2, 0.1, 0.02 mM).
Of these supplements, only methionine pro-
moted significant growth of Sul-r/Met- colonies
on defined agar. Trace activity observed for S-
adenosylmethionine was attributed to methionine,
arising by decomposition. Furthermore, PAB,
vitamin B12, and folic acid (diffusing from sep-
arate discs saturated with 1 mg/ml solutions) did
not increase the growth of Sul-r/Met- strains on
defined agar with 0.005 mm methionine, a sub-
optimal concentration.
Some of the compounds restricted or delayed
growth of the Met+ strain. After 24-hr incubation,
colonies were either absent or small on the highest
concentrations listed of cysteine (also cysteine
plus homoserine, each at 0.25 mM), homocysteine,
homocystine, and S-adenosylmethionine. No ef-
fect was found with lower concentrations. Me-
thionine did not affect colonial growth of Ne 15
Met+ at concentrations below 0.05 mM; however,
above 0.5 mm, a temporary inhibition was evident.
This inhibitory effect, which was marked with 5.0
mM methionine, resembles the regulation of
methionine biosynthesis in E. coli, in which
methionine represses the formation of enzymes
required for its own synthesis (21, 33).
Growth of Sul-r/Met- strains on defined agar
was optimal with methionine at 0.1 to 0.5 mm.
As with the parent strain, their growth was in-
hibited progressively by concentrations higher
than 1.0 mm. At suboptimal concentrations, the
size of colonies was a sensitive indicator of avail-
able methionine [including that amount which
might be introduced as a contaminant of "pure"
amino acids (9, 27)]. Colonies on defined agar
with 0.0005 mm methionine were barely visible
after incubation for 24 hr, and thereafter in-
creased in size only slightly if at all. No isolated
colonies were macroscopically visible in 24 hr on
unsupplemented defined agar cultures of any
Sul-r/Met- strain, but after longer incubation
microcolonies could be detected with 4 x magni-
fication. The strains differed from one another
only slightly in regard to the size of these micro-
colonies, although their sulfadiazine resistances
differed considerably.
In a further attempt to discern some relation
between amount of methionine required and
concentration of sulfadiazine tolerated, strains of
differing resistance were streaked on defined agar
lacking serine but containing five different con-
centrations of methionine alone or in combina-
tion with sulfadiazine (0.05 and 0.1 ,ug/ml, sep-
arate series). A concentration of 0.05 ,tg of
sulfadiazine per ml in the defined agar, either with
or without methionine, was sufficient to inhibit
growth of the parent strain. (At lower concentra-
tions of sulfadiazine, methionine exerted an
antagonizing action, as expected.) All of the Sul-
r/Met- strains could tolerate 0.05 and 0.1 ,tg of
sulfadiazine per ml. (Some were inhibited by 0.5
,ug/ml.) Their colony size was determined, as on
drug-free medium, by time of incubation and
concentration of methionine. Thus, the challenge
of a low dose of sulfadiazine did not affect the
degree of response to methionine of the various
Met- strains, though they differed in degree of
resistance.
Transformation ofMetr strains. To obtain basic
knowledge of the particular met locus which
controls the Sul-r/Met- phenotype, a preliminary
study was made of spontaneous mutants of strain
Ne 15. Colonies, picked from sulfadiazine-con-
taining HIY-1 agar, were subcultured on sulf-
adiazine-free agar and screened for methionine
requirement and genetic stability. DNA was
extracted from six of these Sul-r/Met- mutants.
Ml and M33 were strains which had been isolated
from agar containing 20 Mg of sulfadiazine per ml,
M54 and M58 were from 50,g/ml, and M61 and
M69 were from 100lg/ml. All six DNA prepara-
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tions had transforming activity for the parent
strain Ne 15; as expected, transformants were
exclusively Sul-r/Met-.
Each DNA was examined in quantitative trans-
formation tests (method A, described in Materials
and Methods), with suspensions of each of the
six Sul-r/Met- strains serving as recipient. Such
tests should yield prototrophic recombinants if
the met locus involved is genetically complex, as,
for example, has been shown for other met loci
(36) and the amiA region (13). Thus, information
needed to correct the genetic defect and restore
the biosynthetic function of one Sul-r/Met-
mutant can be supplied by transforming DNA
from a differently defective Sul-r/Met- strain, but
not from an identical mutant. The results (Table
4) confirmed this expectation. Each DNA showed
transforming activity for practically all recipients
except the one from which the DNA was ob-
tained. That is, DNA from one mutant provided
no information to repair the defect of the same
mutant because the genetic alteration was identi-
cal; however, it did furnish information to other
phenotypically similar mutants, indicating the
nonidentity of their mutant sites.
Two additional DNA preparations examined
in other tests (7, 8, Table 2) were included in all
these experiments (Tables 4, 5). The str gene pro-
vided a reference marker outside the met locus for
measuring competence of the strain. DNA from
the Sul-r20 Met+ strain was used to determine the
efficiency of the process of genetic elimination of
the mutant site by the wild-type met locus. The
frequency of transformation of Met- recipients
by this preparation (one-point cross) was always
higher than that found in tests of the DNA from
Met- strains (two-point crosses), implying some
degree of linkage between the mutant met sites of
donor and recipient (13). Close linkage of the
mutant sites of M54 and M58 was indicated by
the very low frequencies of reciprocal transforma-
tion. However, nonidentity of these sites was
revealed by other tests with a Sul-r/Met- recip-
ient (Ml 13) which was transformed by DNA
from M54 but not from M58.
Strain Ne 15 Sul-r/Met- Str-r 64 was a multi-
step Sul-r mutant; that is, its high degree of
sulfadiazine resistance was the result of multiple
independent mutations. Its responses as recipient
("64") are given in Table 4. Its DNA, which
transformed all strains to streptomycin resistance,
likewise elicited Met+ transformants from Ml,
M33, M54, and M58. However, Met+ trans-
formants of M69 were very rare, and they were
not detected with M61, suggesting that the altered
sites of these mutants might lie close to or overlap
those of "64." Furthermore, Met+ transformants
of "64" were not detected after treatment with
DNA (result not tabulated) from a multistep
Sul-r/Met- strain of N. perflava Ne 16 (the DNA
used in test 9, Table 2). Prototrophic transform-
ants were elicited, however, in the approximately
reciprocal test performed with "64" DNA and the
recipient strain p8(16), which originated as a
TABLE 4. Numbers ofprototrophic transformants obtained in tests of various Neisseria meningitidis Ne 15
Sul-r/Met- recipients treated with DNA from the same strains
DNA prepn
Ml
M33
M54
M58
M61
M69
Ne 15 Sur-r/Met-
Str-r 64
Ne 15 Sul-r20
Met+ 16
Recipient strains'
Ml
0
34
14
16
34
25
101
3, 514b
1,568
M33
80
0
120
80
114
143
641
4,246b
1,816
M54
16
36
0
0.4
11
17
34
1,611b
456
M158
53
91
0.4
0
62
89
234
3,615b
2,010
M61
122
147
113
105
0
26
0
1, 960b
1,125
M69
40
76
37
45
7
0
0.2
2, 260b
646
"64"
4
20
5
12
0
0
0
692
p8(16)
32
76
79
78
32
28
596
2, 196b
3,269
a Each column gives results (expressed as number of transformants/106 treated cells) of tests of one
recipient strain with eight DNA preparations. Reaction mixtures in methionine-free defined fluid con-
tained cells plus 5 ,ug of DNA/ml; deoxyribonuclease was added after 30 min.
b Str-r transformants. All other transformants were Met+.
c Recipient was Str-r, and was the donor strain for the DNA used in this test.
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TABLE 5. Numbers ofprototrophic transformants obtained in tests of various Neisseria meningitidis Ne 15
Sul-r/Met- recipients treated with DNA from Sul-r/Met- Neisseria
Recipient strain
DNA prepn
g45(VI) g17(VII) g3(VIII) g4(IX) g47 (X) g49(XI) 1(64)
(6.9 X 106)a (7.4 X 106) (34 X 106) (28 X 106) (20 X 106) (29 X 106) (7.8 X 106)
VI 0 232 0 0 0 483 71
VII 1 0 0 0 0 32 0
VIII 0 0 0 0 0 0 0
IX 0 0 0 0 0 0 0
X 0 5 0 0 0 0 0
XI 1 125 0 0 0 0 0
Ml 15 21 0 0 0 201 236
M33 60 118 0 0 0 452 453
M54 46 79 0 0 0 344 185
M58 60 101 0 0 0 242 203
M61 17 3 0 0 0 10 0
M69 14 14 0 0 0 78 0
Ne 15 Sul-r/Met- Str-r 64 170 0 0 0 0 0 0
11,970b 20,330b 17,320b 19,700b 13,970b 12,030b 12,360b
Ne 15 Sul-r20 Met+ 16 7,660 13,380 2,800 3,110 3,960 3,170 7,920
a Total number of treated recipient cells. Results of tests in defined fluid (containing 10-6 M methi-
onine) with one cellular suspension, samples of which were treated with the various DNA prepara-
tions (10 jug/ml).
b Str-r transformants. All other transformants were Met+.
Sul-r/Met- transformant of Ne 15 treated with
N. perflava DNA (as in test 9, Table 2). Thus,
multistep Sul-r mutants were not necessarily alike
in their ability to receive or to provide informa-
tion affecting this met locus.
Transformation tests were performed by using,
as recipients, Sul-r/Met- transformant strains
which were isolated in tests (comparable to those
of Table 3) of Ne 15 cells with the gonococcal
DNA preparations VI-XI. Work with these recip-
ients was complicated by their tendency to lose
viability in the methionine-free defined fluid re-
action mixtures. The decline of viability began
after about 30 to 40 min and appeared to be a
function of the initial numbers of cells, as if leak-
age of nutrients from cells of a large population
provided some protection. Therefore, to test one
cellular suspension against 15 to 20 DNA prep-
arations without invalidating the transformation
results by the lethality reaction, a more rapid,
semiquantitative assay was used (method B,
Materials and Methods), except for the two con-
trol tests (bottom of Table 5) which yielded
numerous transformation colonies. Also, a mini-
mal concentration of methionine (10-6 M) was
included in the defined fluid of the reaction mix-
tures. Met+ spontaneous mutants were not ob-
served on any methionine-free agar plates inoc-
ulated with these recipients which had been
exposed to deoxyribonuclease-treated DNA.
The transformation pattern shown by each of
these Sul-r/Met- recipients in two-point crosses
clearly distinguished the genetic defects of DNA
VI, VII, and XI (Table 5). DNA VIII, IX, and X
were different from the others, but resembled one
another. [Two of these gonococcal strains were
separate isolates from the same patient (Table 1).]
Genetic information was neither given by these
gonococcal DNA preparation [except DNA X in
the reaction with g17 (VII)], nor received by the
Ne 15 transformants which carried their defects.
However, as expected, these defects could be
eliminated by transformation with DNA having
the wild-type locus (Ne 15 Sul-r20 Met+ 16).
The pattern of response obtained with recipient
"64," discussed in connection with Table 4, was
similar to that of recipient 1(64), shown in Table
5. Another recipient 2(64) also was similar. As
strains 1(64) and 2(64) were derived by trans-
formation of Ne 15 with DNA from "64" (test 8,
Table 2), the met lesions of all three should be
identical. Such findings provide further justifica-
tion for using results obtained with transformants
as a basis for inference concerning genotypes of
DNA donors.
Restoration of the Sul-s phenotype. The reaction
of N. meningitidis Ne 15 cells (Sul-s Met+) with
N. gonorrhoeae DNA VI or DNA VII resulted in
transformants resistant to 150 ,g/ml or higher
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concentrations of sulfadiazine (Table 3), all of
which were Met-. Cells transformed by DNA
VII served as recipients in a subsequent trans-
formation reaction with DNA VI, and yielded
Met+ transformants (Table 5). If the resistance
and methionine requirement are dual effects of
one underlying genetic change, as proposed, then
the return to prototrophy should be associated
with a restoration of susceptibility.
To investigate this relationship, Met+ colonies
picked from the transformation plates were sub-
cultured once on HIY-1 agar. Diluted suspensions
prepared from young cultures were quantitatively
plated by the overlay method in sulfadiazine-free
HIY-1 agar and in agar containing 20 ,g of
sulfadiazine per ml. No growth in the latter (or, at
most, rare Sul-r mutants) compared with essen-
tially confluent growth in the former, testified that
the prototrophs were susceptible to this level of
sulfadiazine. The method was not designed to
answer the technically more difficult question
whether the level of susceptibility was identical to
that of the parent, but rather to obtain unequivo-
cal evidence that the population was susceptible
to 20 Mg of sulfadiazine per ml. This was demon-
strated, without exception, for over 100 Met+
transformant colonies, representing most of the
possible combinations of Met- X Met- indicated
in Tables 4 and 5.
DISCUSSION
Pathogenic strains of Neisseria have en-
countered the challenge of sulfonamide treatment
of their human hosts on innumerable occasions.
Various possible ways were suggested (7) by
which bacteria might become resistant to the anti-
bacterial activity of drugs. Two different mech-
anisms were found among the 11 clinical isolates
examined here.
One type of resistance was demonstrated for
the six N. gonorrhoeae strains isolated during the
period 1940-1946 when sulfonamide therapy was
standard. Their sulfonamide resistance was the
result of genetic alteration of a particular met
locus. This inference is based on the finding that
transforming DNA from each introduces sulf-
adiazine resistance and a requirement for methio-
nine (Sul-r/Met-) concurrently into a meningo-
coccal recipient, which before transformation was
sulfonamide-susceptible and capable of growth in
defined medium without supplemental methionine
(Sul-s Met+). When a Sul-r/Met- transformant
is used as recipient in a transformation test with
DNA from a different Sul-r/Met- strain, Sul-s
Met+ transformants are recovered. The Sul-r/
Met- transformants are enabled to grow in media
containing elevated concentrations of sulfadiazine,
though not as luxuriantly as in the absence of the
drug. Gonococci having these characteristics
would be able to incite infection as usual, as the
host furnishes required nutritional factors.
Though the strains might be considered only
partially resistant on the basis of in vitro tests,
their survival in the treated host must have been
facilitated by the purulent process, which tends
to reduce the antibacterial activity of sulfonamide
(41). Therapeutic failures were recorded in more
than 75% of cases of gonorrhea treated with
sulfonamides during 1945-1948 (31, 37). Within a
decade of the advent of penicillin therapy, how-
ever, sulfonamide-resistant gonococci were re-
duced to their former low incidence (31, 37)
because they were as susceptible to penicillin as
were other gonococci.
The four clinical isolates of N. meningitidis
exhibited a different type of sulfadiazine resist-
ance, which was not associated with increased
auxotrophy. Although the Sul-r/Met- property is
acquired readily by meningococci as a result of
spontaneous mutation or by transformation, the
degree of resistance afforded is less than that
characteristic of the four Sul-r Met+ strains
isolated from patients with meningitis. These are
presumably representative of the highly resistant
group B meningococci, which first attracted atten-
tion in 1963 (28) and subsequently have become
relatively prevalent in some areas of the United
States (26).
The enzymatic basis of sulfonamide resistance
in Neisseria has not been established. However,
evidence available from other investigations sug-
gests that folate compounds are ultimately in-
volved in both types of resistance described here.
Thus, work with cell-free enzymes of E. coli has
revealed that sulfonamides inhibit folate bio-
synthesis by competing with PAB as substrate for
the enzyme system that catalyzes the formation of
dihydropteroic acid from PAB and 2-amino-4-
hydroxy - 6- hydroxymethyldihydropteridine (1).
Furthermore, enzymes extracted from sulfon-
amide-resistant mutants combine with sulfon-
amides less readily than does the corresponding
enzyme extracted from the parent strain (30).
Sulfonamide resistance arising by mutation in
Diplococcus pneumoniae also was shown (39) to be
due to structural alteration of a PAB-utilizing
enzyme, and transformation methods were
applied in genetic analysis of the resistant mutants
(17). Similarly, the Sul-r Met+ meningococcal
strains may possess genetically altered enzymes
for catalyzing this step of folate biosynthesis.
In enteric bacteria, the conversion of homo-
cysteine to methionine is a complex reaction
which involves the creation of the methyl group
as methyltetrahydrofolate, and its subsequent
transfer to homocysteine by either of two enzyma-
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tic mechanisms (6). The met locus affected in N.
meningitidis resembles the metF locus of S. typhi-
murium (36) and Proteus mirabilis (14) in that the
requirement is satisfied by methionine only. S.
typhimurium metF100 lacks N5N10-methylene-
tetrahydrofolate reductase, which catalyzes the
reduction of N5N10-methylenetetrahydrofolate to
N5-methyltetrahydrofolate (6). If the Sul-r/Met-
strains of Neisseria are genetically similar to
metF, their defects likewise must involve altera-
ions of the corresponding reductase.
Whether meningococcal auxotrophs blocked at
other steps of the methionine biosynthetic path-
way are also sulfadiazine-resistant is not known
yet. With E. coli mutants auxotrophic for homo-
cysteine or for vitamin B12, the minimal inhibitory
concentration of sulfathiazole showed a 20-fold
increase in the presence of B12 or methionine (8).
[The relation between vitamin B12 and methionine
has been clarified recently; see Cauthen et al.
(6).] Possibly, any genetic event which imposes a
requirement for exogenous methionine simul-
taneously confers some degree of sulfonamide
tolerance by exerting a sparing effect on the
available single-carbon units. Such a change,
simultaneously affecting two properties, is not
unique. Recent reports have documented the con-
current appearance of resistance to aminopterin
and a specific sensitivity (34), and of resistance to
other inhibitors of dihydrofolate reductase con-
currently with nutritional requirements for certain
end products of biosyntheses involving tetra-
hydrofolate-containing coenzymes (35).
As a selective agent for auxotropic mutants of
Neisseria, sulfadiazine appears to be quite specific
for spontaneous mutations which affect the par-
ticular locus corresponding to metF of Salmonella
(36). This locus of Neisseria was revealed to be
complex, having a number of sites which undergo
recombination. Additional evidence that the
number of sites is large is provided by results of
transformation tests (to be described elsewhere)
with 89 Sul-r/Met- spontaneous mutants. These
were used as recipients in two-point crosses with
six DNA preparations (Table 4) from Sul-r/Met-
mutants; the transformation patterns indicated
that not more than 3 of the 89 were possibly the
same as any of the 6 DNA donor mutants. This
met locus is of considerable interest, therefore,
because it promises to be a powerful tool for
study of genetic fine structure of members of
Neisseria, and of genetic homology. The data
presented here (Tables 4 and 5), furthermore,
reveal a correspondence of metF loci of N.
meningitidis, N. gonorrhoeae, and N. perflava.
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